Charles River Newsroom

Earnings Preview: CRL to Report Financial Results Pre-market on November 06

$Charles River(CRL.US)$ is scheduled to release its financial results pre-market on November 06 ET. Earnings PreviewAnalysts estimate $Charles River(CRL.US)$ to post revenue of USD975.50M for 2024Q3,

Futu NewsNov 1 09:00

Charles River Associates Shares Are Trading Lower. The Company Reported Q3 Financial Results.

BenzingaNov 1 00:25

Charles River Associates Reaffirmed FY24 Revenue Outlook At $670M - $685M, Est $675.9M

BenzingaOct 31 20:24

Earnings Flash (CRAI) CHARLES RIVER ASSOCIATES Posts Q3 EPS $1.77

MT NewswiresOct 31 20:06

Press Release: Charles River Associates (CRA) Reports Financial Results for the Third Quarter of 2024

Dow JonesOct 31 20:05

Express News | Charles River Associates (CRA) Reports Financial Results for the Third Quarter of 2024

BreakingsOct 31 20:05

Press Release: Charles River Associates (CRA) Declares Quarterly Cash Dividend of $0.49 Per Common Share

Dow JonesOct 31 20:03

Why Charles River (CRL) Is Poised to Beat Earnings Estimates Again

Yahoo FinanceOct 30 00:10

P/E Ratio Insights for Charles River

BenzingaOct 26 01:47

Possible Bearish Signals With Charles River Laboratories International Insiders Disposing Stock

Simply Wall StOct 25 22:52

ICON Leads a Selloff Among CROs After Guidance Cut; Baird Downgrades

Seeking AlphaOct 25 02:32

This Ferguson Enterprises Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

BenzingaOct 23 20:52

CLSA Initiates Coverage On Charles River With Underperform Rating, Announces Price Target of $167

Analyst UpgradesOct 23 18:46

FibroBiologics and Charles River Link for Chronic Disease Therapies Manufacture

Yahoo FinanceOct 21 19:45

Express News | Fibrobiologics Inc: Cywc628, for Utilization in a Diabetic Foot Ulcer (Dfu) Clinical Trial Slated to Begin in 2025.

BreakingsOct 18 20:30

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

GlobeNewswireOct 18 20:30

Express News | Fibrobiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-Based Therapies for Chronic Diseases

BreakingsOct 18 20:30

Charles River Launches New Retrogenix Non-Human Protein Library

BusinesswireOct 17 20:00

Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call

BusinesswireOct 17 04:30

MeQuilibrium Honors JPMorganChase, Dow Chemical, Liberty Mutual Insurance, Leidos, KBR, Charles River Labs, Point32 Health, and Qurate Retail Group for Achievements in Supporting Employee Resilience

PR NewswireOct 16 20:32